Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Tamoxifen for Radiation-Induced Breast Cancer Risk Reduction
NCT01196936Phase 2Active, not recruiting
- Sponsor
- University of Alabama at Birmingham
- Start
- Sep 2010
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in breast cancer comparing Arm I (tamoxifen citrate) with Arm II (placebo) (2 arms). Primary endpoint: Mammographic Breast Density at 2 years. Started Sep 2010; status: active, not recruiting.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01196936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01196936.